Cloning, Expression and Preliminary Studies on Bioactivities of HA1 Segment of H9 Subtype Avian Influenza Virus

LEI Ting,CHEN Chen,WU Shan,CAO Hong,CHEN Fu-yong

DOI: https://doi.org/10.3969/j.issn.1008-0589.2006.06.008

2006-01-01

Abstract:According to the sequence of HA that was published on GenBank,HA1 gene of an AIV isolate, A/Chicken/Beijing/1/96(H9N2),was amplified.The sequence of HA1 gene showed 95%-98% homologous compared with other published HA1 sequence.The fragment of HAl was cloned into expression plasmid pET-28a.And the recombinant plasmid DNA was named as pET28-H9HA1.Then it was transformed in E.coli BL21(DE3).There were two pieces of recombinant fusion protein expressed in E.coli BL21(DE3)induced by IPTG and the molecular weight were 42 Ku and 23 Ku,respectively, by SDS-PAGE and Western blot.The fusion protein did not cause hemagglutination by hemagglutination(HA)test.The positive serum did not cause hemagglutination inhibiting by hemagglutination inhibition(HI)test.The protein exhibited specific binding to antiviral antibodies of H9 subtype and has no cross-reaction with H5 or H7 subtype or other avian infectious diseases.The results above showed the expressed HA1 recombinant protein shared good reactinogenicity and specificity and could be developed as a new diagnostic reagent for H9 subtype AIV.